B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CSNK2A1

MOLECULAR TARGET

casein kinase 2 alpha 1

UniProt: P68400NCBI Gene: 145715 compounds

CSNK2A1 (casein kinase 2 alpha 1) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CSNK2A1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Apigenin 5,7,4'-trihydroxy-flavone,2.7114
2Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as2.7114
3Quercetin2.4010
4fisetin1.956
5Kaempferols1.614
6Luteolin 5,7,3',4'-tetrahydroxy-flavone,1.614
7myricetin-3-O-galactopyranoside [Supplementary Concept]1.614
8chrysin1.102
9Dichlororibofuranosylbenzimidazole1.102
10Vanillic Acid1.102
11ly2940021.102
12Adenylyl Imidodiphosphate 5'-Adenylic acid, monoanhydride with imidodiphosphoric acid.0.691
13alsterpaullone0.691
14kenpaullone0.691
15sp6001250.691

About CSNK2A1 as a Drug Target

CSNK2A1 (casein kinase 2 alpha 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented CSNK2A1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CSNK2A1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.